A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+26.78%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
AUM
$144M
AUM Growth
+$144M
Cap. Flow
-$7.32M
Cap. Flow %
-5.07%
Top 10 Hldgs %
90.35%
Holding
19
New
3
Increased
Reduced
3
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CRSP icon
1
CRISPR Therapeutics
CRSP
$4.71B
$35.1M 24.33% 1,971,907 -472,902 -19% -$8.43M
SIEN
2
DELISTED
Sientra, Inc.
SIEN
$33.8M 23.42% 2,199,012
PRTK
3
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$26.1M 18.09% 1,041,131 -259,301 -20% -$6.51M
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
$12.4M 8.6% 1,542,722 -57,278 -4% -$461K
CHMA
5
DELISTED
Chiasma, Inc. Common Stock
CHMA
$5.31M 3.67% 2,080,595
TARA icon
6
Protara Therapeutics
TARA
$120M
$3.94M 2.72% 2,017,872
CASC
7
DELISTED
Cascadian Therapeutics, Inc.
CASC
$3.78M 2.62% 925,000
IMDZ
8
DELISTED
Immune Design Corp.
IMDZ
$3.65M 2.52% 352,300
OBSV
9
DELISTED
ObsEva SA Ordinary Shares
OBSV
$3.48M 2.41% +440,000 New +$3.48M
CLLS
10
Cellectis
CLLS
$258M
$2.84M 1.97% 100,000
ONCT
11
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$2.78M 1.93% +339,174 New +$2.78M
ADAP
12
Adaptimmune Therapeutics
ADAP
$15.6M
$2.05M 1.42% 250,000
RARE icon
13
Ultragenyx Pharmaceutical
RARE
$2.89B
$2.03M 1.4% +38,100 New +$2.03M
DERM
14
DELISTED
Dermira, Inc.
DERM
$1.89M 1.31% 70,000
OCGN icon
15
Ocugen
OCGN
$319M
$1.76M 1.22% 888,889
AUPH icon
16
Aurinia Pharmaceuticals
AUPH
$1.58B
$1.58M 1.09% 252,129
EVAR
17
DELISTED
Lombard Medical, Inc.
EVAR
$1.53M 1.06% 3,473,452
INNL
18
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$322K 0.22% 537,235
NOVN
19
DELISTED
Novan, Inc. Common Stock
NOVN
-53,367 Closed -$215K